Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 3/2009

01-10-2009

Risk stratification for venous thromboembolism in hospitalized patients in a developing country: a prospective study

Authors: Abdallah Awidi, Nathir Obeidat, Ahmad Magablah, Nazzal Bsoul

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2009

Login to get access

Abstract

Venous Thrombo-Embolism (VTE) is a serious complication in hospitalized patients but can be preventable. This prospective study addresses risk factors assessment and the use of heparin in this population. About 2,496 non pediatric patients were admitted to Jordan University Hospital between June 12, 2007 and July 19, 2007. A random sample of 624 patients consisting of every fourth admission was chosen. The stratification of risk factors was assessed using Caprini model and the ACCP score. The mean age of the patients (229 males and 395 females) was 45.34 ± 18.3 years. More than 80% of the admitted patients were considered at high risk for VTE but heparin was used in only 26% of the patients. The majority of our patients constitute a high-risk population. Implementation of strategies including educational sessions and risk stratification guidelines can reduce the incidence, morbidity, and mortality of VTE especially in developing countries.
Literature
3.
go back to reference Rosendaal FR (1999) Risk factors for venous thrombotic disease. Thromb Haemost 82:610–619PubMed Rosendaal FR (1999) Risk factors for venous thrombotic disease. Thromb Haemost 82:610–619PubMed
5.
go back to reference Prandoni P (2005) Acquired risk factors for venous thromboembolism in medical patients. ASH Educ Book 2005:458–461 Prandoni P (2005) Acquired risk factors for venous thromboembolism in medical patients. ASH Educ Book 2005:458–461
8.
go back to reference Cohen AT, Agnelli G, Anderson FA et al (2007) Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 98(4):756–764PubMed Cohen AT, Agnelli G, Anderson FA et al (2007) Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 98(4):756–764PubMed
10.
11.
go back to reference Awidi A, Shannak M, Bseiso A et al (1999) High prevalence of factor V Leiden in healthy Jordanian Arabs. Thromb Haemost 81(4):582–584PubMed Awidi A, Shannak M, Bseiso A et al (1999) High prevalence of factor V Leiden in healthy Jordanian Arabs. Thromb Haemost 81(4):582–584PubMed
13.
go back to reference Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ, American College of Chest Physicians (2008) Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 133(6, Suppl):454S–545S. doi:10.1378/chest.08–0658 Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ, American College of Chest Physicians (2008) Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 133(6, Suppl):454S–545S. doi:10.​1378/​chest.​08–0658
14.
go back to reference Masroujeh R, Shamseddeen W, Isma’eel H et al (2007) Underutilization of venous thromboemoblism prophylaxis in medical patients in a tertiary care center. J Thromb Thrombolysis 15. [Epub ahead of print] Masroujeh R, Shamseddeen W, Isma’eel H et al (2007) Underutilization of venous thromboemoblism prophylaxis in medical patients in a tertiary care center. J Thromb Thrombolysis 15. [Epub ahead of print]
15.
go back to reference Dh te R, Pellicer-Coeuret M, Belouet-Moreau C et al (2001) Venous thromboembolism in medical inpatients: prophylaxis with low-weight heparin in a university hospital and prevalence of thromboembolic events. Clin Appl Thromb Hemost 7(1):16–20. doi:10.1177/107602960100700104 PubMedCrossRef Dh te R, Pellicer-Coeuret M, Belouet-Moreau C et al (2001) Venous thromboembolism in medical inpatients: prophylaxis with low-weight heparin in a university hospital and prevalence of thromboembolic events. Clin Appl Thromb Hemost 7(1):16–20. doi:10.​1177/​1076029601007001​04 PubMedCrossRef
18.
19.
go back to reference Jaffer AK, Amin AN, Brotman DJ, Deitelzweig SB, McKean SC, Spyropoulos AC (2008) Prevention of venous thromboembolism in the hospitalized medical patient. Cleve Clin J Med 75(Suppl 3):S7–S16PubMedCrossRef Jaffer AK, Amin AN, Brotman DJ, Deitelzweig SB, McKean SC, Spyropoulos AC (2008) Prevention of venous thromboembolism in the hospitalized medical patient. Cleve Clin J Med 75(Suppl 3):S7–S16PubMedCrossRef
Metadata
Title
Risk stratification for venous thromboembolism in hospitalized patients in a developing country: a prospective study
Authors
Abdallah Awidi
Nathir Obeidat
Ahmad Magablah
Nazzal Bsoul
Publication date
01-10-2009
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2009
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-008-0291-1

Other articles of this Issue 3/2009

Journal of Thrombosis and Thrombolysis 3/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine